FINKELSTEIN J J 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jul 19, 2018
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-07-17$0.21/sh+250,000$52,500→ 250,000 totalExercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying)
Holdings
- 1,637,991
Common Stock
Footnotes (1)
- [F1]The option vests in four equal installments of 62,500 shares on each of July 17, 2018, 2019, 2020 and 2021.